| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sana Biotechnology, Inc. | EVP & General Counsel | Common Stock | 112,990 | $289,254 | $2.56 | 10 Mar 2025 | Direct |
| Sana Biotechnology, Inc. | EVP & General Counsel | Restricted Stock Units | 33,126 | $84,803 | $2.56 | 07 Mar 2025 | Direct |
| Sana Biotechnology, Inc. | EVP & General Counsel | Stock Option (Right to Buy) | 240,000 | 06 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | 06 Mar 2025 | 5 | -$7,252 | 4 | EVP & General Counsel | 10 Mar 2025, 20:12 |
| SANA | Sana Biotechnology, Inc. | 07 Mar 2024 | 2 | $0 | 4 | EVP & General Counsel | 08 Mar 2024, 16:16 |
| SANA | Sana Biotechnology, Inc. | 02 Mar 2023 | 1 | $0 | 4 | EVP & General Counsel | 03 Mar 2023, 15:35 |
| SANA | Sana Biotechnology, Inc. | 15 Sep 2022 | 1 | $0 | 4 | EVP & General Counsel | 16 Sep 2022, 18:52 |
| SANA | Sana Biotechnology, Inc. | 12 Sep 2022 | 0 | $0 | 3/A | EVP & General Counsel | 20 Sep 2022, 16:05 |